BioSpace News Archive

FAU Receives $1.3 Million NIH Grant for Prosthesis Project [15-November-2017] BOCA RATON, Fla., Nov. 15, 2017 /PRNewswire-USNewswire/ -- The sense of touch is often taken for granted. For someone without a limb or hand, losing that sense of touch can be devastating. While highly sophisticated prostheses with complex moving fingers and joints are available to

The center will accelerate the transfer of stem cell-organoid technology from the research lab to practical clinical tool.

Adds patient-centric hospital-wide imaging capabilities, and new cloud-based managed services for high reliability and uptime.

Early physician and patient experiences with Cardea SOLO are confirming the FDA-cleared cardiac device, designed to streamline arrhythmia detection in patients, is providing a higher standard of ambulatory cardiac care and efficiencies in cardiac practices.

The company’s line of iReliev brand products offer consumers FDA cleared tools for non-invasive, drug-free pain relief and muscle conditioning.

Total sales of $3,600,000 for the quarter ended September 30, 2017 compared to $3,018,000 in Q3 2016;

Quanta, a biotech firm specializing in resonance energy, today announced the launch of its patented technology into the cannabis industry.

The test can identify synthetic urine as well as samples that might be obtained from a friend or relative.

As previously announced, Merck is responsible for all future product development expenses for the selected antibody and Agenus is eligible to receive up to an additional $99M in milestone payments, as well as royalties on worldwide product sales.

There were no device-related adverse events or infections and primary patency was maintained in 97.6% of procedures.